ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,856Medicare Part D Prescriptions Filled, Including Refills

Rank: 617 out of 2343

$545K Total Retail Price of All Prescriptions

Rank: 576 out of 2343

550 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,431 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 375 343 1 1
OMEPRAZOLE 270 250 2 4
ENALAPRIL MALEATE 257 229 3 58
FUROSEMIDE 244 238 4 6
LEVOTHYROXINE SODIUM 221 216 5 2
METFORMIN HCL 210 199 6 9
ATENOLOL 204 203 7 12
AMLODIPINE BESYLATE 204 193 7 5
ATORVASTATIN CALCIUM 193 183 9 10
PRAVASTATIN SODIUM 190 177 10 15
LISINOPRIL 188 188 11 3
METOPROLOL TARTRATE 188 186 11 7
HYDROCHLOROTHIAZIDE 182 177 13 11
LOVASTATIN 178 160 14 47
CARVEDILOL 167 163 15 27
GABAPENTIN 161 158 16 16
CITALOPRAM HBR 149 148 17 17
CLOPIDOGREL 120 120 18 26
DIOVAN 117 102 19 23
ZETIA 112 112 20 52
LOSARTAN POTASSIUM 108 101 21 19
POTASSIUM CHLORIDE 106 104 22 18
DILTIAZEM 24HR ER 104 104 23 76
EVISTA 103 92 24 128
SERTRALINE HCL 98 94 25 20
PLAVIX 97 97 26 38
TRIAMTERENE-HCTZ 91 87 27 57
GLIPIZIDE 90 89 28 56
NIFEDICAL XL 85 69 29 148
NEXIUM 81 78 30 33
WARFARIN SODIUM 80 80 31 8
LEVOXYL 77 70 32 237
DONEPEZIL HCL 73 60 33 21
HYDROCODONE-ACETAMINOPHEN 70 66 S3 34 13
PANTOPRAZOLE SODIUM 69 65 35 22
SPIRONOLACTONE 68 68 36 65
DILTIAZEM 24HR CD 68 65 36 83
ALENDRONATE SODIUM 68 68 36 28
DIGOXIN 66 64 39 35
SYNTHROID 65 65 40 40
FAMOTIDINE 61 60 41 60
LABETALOL HCL 59 59 42 153
GEMFIBROZIL 57 45 43 133
ADVAIR DISKUS 56 54 44 34
VERAPAMIL ER 55 51 45 95
NIFEDIPINE ER 54 54 46 89
ALLOPURINOL 53 46 47 31
ZOLPIDEM TARTRATE 52 52 48 24
PROAIR HFA 50 50 49 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.